Skip to main content
. 2018 Oct 18;10:149–164. doi: 10.2147/OAEM.S181222

Table 1.

Inclusion and exclusion criteria used in the review of available literature

Inclusion criteria Exclusion criteria

Publications were included that Publications were excluded that
• Discussed the clinical application of inhaled methoxyflurane at analgesic doses in pain or medical procedures
• Related solely to the treatment of trauma pain in specific patient groups including pediatrics, elderly
• Related to the treatment patterns and pain management of moderate to severe trauma pain
• Explored the safety or inhaled analgesic methoxyflurane with respect to health and safety of healthcare workers and patients
• Discussed the use of inhaled methoxyflurane at anesthetic dosing
• Were not conducted in patients or were not focused on human data
• Did not report on pain or treatment for pain (emergency or procedural)
• Focused on long-term or chronic pain
• Focused on the treatment of pain in major trauma
• Related solely to patients whose treatment would be outside the legal licensed indication for inhaled analgesic methoxyflurane including pregnant patients or patients with reduced consciousness